American Society of Anesthesiologists Announces RIVANNA Has Joined ASA's Innovator Supporter Program

CHICAGO – The American Society of Anesthesiologists (ASA) today announced RIVANNA has joined ASA’s Innovator Supporter Program, working to share innovation and collaborate closely with the Society’s more than 59,000 anesthesiologists by developing solutions that address real-world clinical needs. RIVANNA’s next-generation, AI-enabled ultrasound imaging technology brings the proven benefits of ultrasound to neuraxial anesthesia, providing real-time guidance for spinal and epidural procedures.

“We are delighted to collaborate with RIVANNA as one of the first companies to join our new ASA Innovator Supporter Program,” said ASA President Donald E. Arnold, M.D., FACHE, FASA. “Their commitment to improving technology to increase patient safety by addressing unexplored health care challenges aligns with ASA’s vision as a world leader in improving health through innovation for quality and safety. ASA’s collaboration with RIVANNA will support our members through educational content and participation at our meetings including at ANESTHESIOLOGY^® 2025.”

Launched in 2025, the Innovator Supporter Program creates a pathway for emerging companies to engage with ASA and its members and underscores ASA’s commitment to fostering innovation in anesthesiology. The year-round program provides needed support for ASA’s most important initiatives. Through the collaboration, organizations develop strong, meaningful relationships with anesthesiologists and the anesthesia community.

Through the various benefits, ASA Innovator Supporters interact with ASA members, physician leaders, and staff, allowing for collaboration on important initiatives to support education, quality, and member resources. The dialogue provided through the Innovator Supporter Program is exclusive to the organizations that participate.

“Collaborating with ASA and its community is a valuable partnership that supports the continued development of imaging solutions for spinal needle interventions with meaningful real-world impact,” said RIVANNA Senior Director of Market Access and Strategic Partnerships Delphine Le Roux, Ph.D. “This collaboration gives RIVANNA ongoing opportunities for joint initiatives throughout the year. Together, we will benefit from a year-round platform for knowledge-sharing and innovation that deepens collaboration between physician anesthesiologists and RIVANNA — an alliance that will help us advance our mission to elevate the standard of care.”

About RIVANNA
RIVANNA® is a commercial-stage medical device innovator and manufacturer based in Charlottesville, VA. RIVANNA develops and commercializes world-first, imaging-based medical technologies that elevate global standards of care. The company provides early- and late-stage comprehensive imaging solutions for point-of-care spinal needle interventions and musculoskeletal diagnostics. Learn more: RIVANNA.

About the American Society of Anesthesiologists
Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 59,000 members organized to advance the medical practice of anesthesiology and secure its future. ASA is committed to ensuring anesthesiologists evaluate and supervise the medical care of all patients before, during, and after surgery. ASA members also lead the care of critically ill patients in intensive care units, as well as treat pain in both acute and chronic settings.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about how anesthesiologists help ensure patient safety, visit asahq.org/madeforthismoment. Join the #ANES25 conversation on social media. Follow ASA on Facebook, X, Instagram, Bluesky, and LinkedIn.

# # #